Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Emerging targets of inflammation and tear secretion in dry eye disease.

Markoulli M, Hui A.

Drug Discov Today. 2019 Feb 22. pii: S1359-6446(18)30395-7. doi: 10.1016/j.drudis.2019.02.006. [Epub ahead of print]

PMID:
30802601
2.

In vitro release of two anti-muscarinic drugs from soft contact lenses.

Hui A, Bajgrowicz-Cieslak M, Phan CM, Jones L.

Clin Ophthalmol. 2017 Sep 14;11:1657-1665. doi: 10.2147/OPTH.S141404. eCollection 2017.

3.

Contact lenses for ophthalmic drug delivery.

Hui A.

Clin Exp Optom. 2017 Sep;100(5):494-512. doi: 10.1111/cxo.12592. Review.

PMID:
28940532
4.

In Vivo Studies Evaluating the Use of Contact Lenses for Drug Delivery.

Hui A, Willcox M.

Optom Vis Sci. 2016 Apr;93(4):367-76. doi: 10.1097/OPX.0000000000000809. Review.

PMID:
26784709
5.

In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses.

Hui A, Willcox M, Jones L.

Invest Ophthalmol Vis Sci. 2014 Jul 15;55(8):4896-904. doi: 10.1167/iovs.14-14855.

PMID:
25028363
6.

Targeted hepatitis C screening among ex-injection drug users in the community.

Wong VW, Wong GL, Chim AM, Cheng TF, Cheung SW, Lai CM, Szeto KJ, Tsang S, Wu SH, Yan KK, Hui AY, Yiu DC, Wu BB, Cheung D, Chung CS, Lai CW, Chan HL.

J Gastroenterol Hepatol. 2014 Jan;29(1):116-20. doi: 10.1111/jgh.12355.

PMID:
24033786
7.

Delivery of ketotifen fumarate by commercial contact lens materials.

Soluri A, Hui A, Jones L.

Optom Vis Sci. 2012 Aug;89(8):1140-9. doi: 10.1097/OPX.0b013e3182639dc8.

PMID:
22773177
8.

Release of Ciprofloxacin-HCl and Dexamethasone Phosphate by Hyaluronic Acid Containing Silicone Polymers.

Nguyen D, Hui A, Weeks A, Heynen M, Joyce E, Sheardown H, Jones L.

Materials (Basel). 2012 Apr 19;5(4):684-698. doi: 10.3390/ma5040684.

9.

Acetic and Acrylic Acid Molecular Imprinted Model Silicone Hydrogel Materials for Ciprofloxacin-HCl Delivery.

Hui A, Sheardown H, Jones L.

Materials (Basel). 2012 Jan 2;5(1):85-107. doi: 10.3390/ma5010085.

10.

Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses.

Boone A, Hui A, Jones L.

Eye Contact Lens. 2009 Sep;35(5):260-7. doi: 10.1097/ICL.0b013e3181b26c49.

PMID:
19657281
11.

Surrogate end points and long-term outcome in patients with chronic hepatitis B.

Wong VW, Wong GL, Chim AM, Choi PC, Chan AW, Tsang SW, Hui AY, Chan HY, Sung JJ, Chan HL.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1113-20. doi: 10.1016/j.cgh.2009.05.025. Epub 2009 Jun 23.

PMID:
19500693
12.

Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis B.

Mihm U, Chan HL, Zeuzem S, Chim AM, Hui AY, Wong VW, Sung JJ, Herrmann E.

Antivir Ther. 2008;13(8):1029-37.

PMID:
19195328
13.

Functional role of the KLF6 tumour suppressor gene in gastric cancer.

Sangodkar J, Shi J, DiFeo A, Schwartz R, Bromberg R, Choudhri A, McClinch K, Hatami R, Scheer E, Kremer-Tal S, Martignetti JA, Hui A, Leung WK, Friedman SL, Narla G.

Eur J Cancer. 2009 Mar;45(4):666-76. doi: 10.1016/j.ejca.2008.11.009. Epub 2008 Dec 26.

14.

Uptake and release of ciprofloxacin-HCl from conventional and silicone hydrogel contact lens materials.

Hui A, Boone A, Jones L.

Eye Contact Lens. 2008 Sep;34(5):266-71. doi: 10.1097/ICL.0b013e3181812ba2.

PMID:
18779666
15.

Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.

Wong VW, Wong GL, Tsang SW, Hui AY, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL.

Antivir Ther. 2008;13(4):571-9.

PMID:
18672536
16.

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

Wong VW, Wong GL, Chim AM, Tse AM, Tsang SW, Hui AY, Choi PC, Chan AW, So WY, Chan FK, Sung JJ, Chan HL.

Am J Gastroenterol. 2008 Jul;103(7):1682-8. doi: 10.1111/j.1572-0241.2008.01933.x. Epub 2008 Jul 4.

PMID:
18616651
17.

Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people.

Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, So WY, Tse AM, Chan FK, Sung JJ, Chan HL.

J Gastroenterol Hepatol. 2008 Jun;23(6):914-21. doi: 10.1111/j.1440-1746.2008.05344.x.

PMID:
18565022
18.

Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.

Yu J, Wu CW, Chu ES, Hui AY, Cheng AS, Go MY, Ching AK, Chui YL, Chan HL, Sung JJ.

Biochem Biophys Res Commun. 2008 Aug 8;372(4):571-7. doi: 10.1016/j.bbrc.2008.05.069. Epub 2008 May 27.

PMID:
18503750
19.

The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.

Yu J, Hui AY, Chu ES, Go MY, Cheung KF, Wu CW, Chan HL, Sung JJ.

Liver Int. 2009 Jan;29(1):25-36. doi: 10.1111/j.1478-3231.2008.01760.x. Epub 2008 Apr 23.

PMID:
18435714
20.

Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B.

Chan HL, Wong VW, Chim AM, Choi PC, Chan HY, Hui AY, Wong GL, Sung JJ.

Antivir Ther. 2007;12(5):815-23.

PMID:
17713165

Supplemental Content

Loading ...
Support Center